MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Cancer
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,325 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,325 works in the cohort · of 4,299,418page 7 of 27

Labels cover 1 of 1,325 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,325 of 1,325 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Congenital abnormalities and childhood cancer
Mohammad Agha, Jack I. Williams, Loraine D. Marrett, Teresa To, Alvin Zipursky, Linda Dodds
2005· article· en· Cancer· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
103
citations
afffundunlabeled
Clinical predictors of gleason score upgrading
Girish S. Kulkarni, Gina Lockwood, Andrew Evans, Ants Toi, John Trachtenberg, Michael A.S. Jewett +2 more
2007· article· en· Cancer· Medicine
distilled prediction:candidate · noneconsensus · none
102
citations
affunlabeled
T‐cell large granular lymphocyte leukemia
Nnenna Osuji, Estella Matutes, Geir E. Tjønnfjord, H. Grech, Ilaria Del Giudice, Andrew Wotherspoon +2 more
2006· review· en· Cancer· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
99
citations
affunlabeled
Similar response rates and superior early progression‐free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma
John Kuruvilla, Tracy Nagy, Melania Pintilie, Richard Tsang, Armand Keating, Michael Crump
2005· article· en· Cancer· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
97
citations
affunlabeled
Key concerns about the current state of bladder cancer
Yair Lotan, Ashish M. Kamat, Michael P. Porter, Victoria Robinson, Neal D. Shore, Michael Jewett +4 more
2009· article· en· Cancer· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
96
citations
affunlabeled
Primary effusion lymphoma
Fadi Brimo, René P. Michel, Karim Khetani, Manon Auger
2007· review· en· Cancer· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
96
citations
aboutno affunlabeled
A longitudinal study of palliative care
Annette S Strömgren, Per Sjøgren, Dorthe Goldschmidt, Morten Aagaard Petersen, Lise Pedersen, Linda Hoermann +1 more
2005· article· en· Cancer· Medicine
distilled prediction:candidate · noneconsensus · none
93
citations
affunlabeled
Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)
Philip A. Philip, Bryan Goldman, Ramesh K. Ramanathan, Heinz‐Josef Lenz, Andrew M. Lowy, Robert P. Whitehead +5 more
2014· article· en· Cancer· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
92
citations

How this was built: Screen · Findings · About